Login / Signup

Membrane cholesterol depletion as a trigger of Nav1.9 channel-mediated inflammatory pain.

Muriel AmsalemCorinne PoilboutGéraldine FerracciPatrick DelmasFrancoise Padilla
Published in: The EMBO journal (2018)
Cholesterol is a major lipid component of the mammalian plasma membrane. While much is known about its metabolism, its transport, and its role in atherosclerotic vascular disease, less is known about its role in neuronal pathophysiology. This study reveals an unexpected function of cholesterol in controlling pain transmission. We show that inflammation lowers cholesterol content in skin tissue and sensory DRG culture. Pharmacological depletion of cellular cholesterol entails sensitization of nociceptive neurons and promotes mechanical and thermal hyperalgesia through the activation of voltage-gated Nav1.9 channels. Inflammatory mediators enhance the production of reactive oxygen species and induce partitioning of Nav1.9 channels from cholesterol-rich lipid rafts to cholesterol-poor non-raft regions of the membrane. Low-cholesterol environment enhances voltage-dependent activation of Nav1.9 channels leading to enhanced neuronal excitability, whereas cholesterol replenishment reversed these effects. Consistently, we show that transcutaneous delivery of cholesterol alleviates hypersensitivity in animal models of acute and chronic inflammatory pain. In conclusion, our data establish that membrane cholesterol is a modulator of pain transmission and shed a new light on the relationship between cholesterol homeostasis, inflammation, and pain.
Keyphrases
  • low density lipoprotein
  • chronic pain
  • neuropathic pain
  • oxidative stress
  • pain management
  • spinal cord
  • spinal cord injury
  • electronic health record
  • intensive care unit
  • hepatitis b virus
  • brain injury
  • drug induced